ArticleArchives of rheumatology2026
Vitamin D Receptor Polymorphisms and Rheumatoid Arthritis Risk: A Systematic Review and Meta-Analysis Evaluating the Moderating Effects of Ethnicity, Bone Erosion, and Classification Criteria.
Article in Archives of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsPrevious studies examining the association between vitamin D receptor (VDR) polymorphisms (ApaI, BsmI, TaqI, FokI) and rheumatoid arthritis (RA) have reported inconsistent findings. This metaanalysis aimed to evaluate whether clinical and population-level factors moderate this association. MATERIALS AND
methodsA systematic review of PubMed, Web of Science, Scopus, Cochrane Library, ClinicalTrials.gov, and Google Scholar was conducted up to July 19, 2024. Observational studies comparing VDR polymorphisms between RA patients and healthy controls were included. Studies without a control group, with fewer than 20 cases, or lacking relevant outcome data were excluded. Methodological quality was assessed using the Newcastle-Ottawa Scale. Random-effects meta-analyses, subgroup analyses, and meta-regression were performed.
resultsTwenty-five case-control studies (3711 RA patients and 3884 controls) were included. No significant overall association was observed between VDR polymorphisms and RA across genetic models. However, subgroup analyses demonstrated ethnic variability, with reduced RA likelihood observed among South Asians for the ApaI dominant model (OR = 0.26, 95% CI: 0.14-0.49) and BsmI polymorphism, while African populations showed increased likelihood for BsmI under the recessive model (OR = 1.77, 95% CI: 1.13-2.78). Meta-regression identified ethnicity, classification criteria, and bone erosion as significant moderators; bone erosion was associated with increased RA likelihood for the FokI dominant model (OR = 2.21, 95% CI: 1.24-3.97).
conclusionAlthough no consistent overall association was identified, the relationship between VDR polymorphisms and RA appears to be modified by ethnicity, classification criteria, and disease severity. These findings underscore the importance of accounting for clinical and population heterogeneity in genetic association studies of RA. Cite this article as: Liu W, Xi S. Vitamin D receptor polymorphisms and rheumatoid arthritis risk: A systematic review and meta-analysis evaluating the moderating effects of ethnicity, bone erosion, and classification criteria. Arch Rheumatol. 2026;41(3):168-187.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.